Komori
Fujikura Composites (5121) · FactResearch and development expenses decreased year on year

Scale of R&D Expenses

First written in FY2016. 22 of 35 entries say "Advanced", first in FY2017. Latest entry: FY2027-H1.

35entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2017 – FY2020-Q3AdvancedFY2023 – FY20252016: 320162017: 420172018: 420182019: 420192020: 320202021: 320212022: 320222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
Decline in R&D ExpenditureA theme 57 companies write about · 52 as a headwind · 4 as a tailwind

47 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 57 companies compared. The sentences above are computed from all 57.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Research and development expenses decreased year on yearAnnual report

    「The Group’s research and development expenditure during the current interim consolidated accounting period was ¥728 million.」

    Research and development expenditure was ¥728 million, down from ¥788 million in the previous interim period. The report states that there were no material changes in the status of research and development activities themselves.
  2. FY2026Research and development expenses decreased year on yearAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,493 million.」

    Research and development expenses amounted to ¥1,493 million, down from ¥1,518 million in the previous fiscal year.
  3. FY2026-H1Research and development expenses decreased year on yearAnnual report

    「Research and development activities across the Group amounted to ¥756 million during the current interim consolidated fiscal period.」

    Research and development activities amounted to ¥756 million, down from ¥788 million in the same period of the previous year. It was stated that there had been no material change in the status of the research and development activities.
  4. FY2025AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,518 million.」

    Research and development expenses amounted to ¥1,518 million, up from ¥1,455 million in the previous fiscal year.
  5. FY2025-H1AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥788 million during the current interim consolidated fiscal period.」

    Research and development activities amounted to ¥788 million during the current interim consolidated fiscal period, up from ¥669 million in the same period of the previous year. It was stated that there had been no material change in the status of the research and development activities.
  6. FY2024AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,455 million.」

    Research and development expenses amounted to ¥1,455 million, up from ¥1,431 million in the previous fiscal year.
  7. FY2024-Q3AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥1,108 million during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥1,108 million for the cumulative third quarter, up from ¥1,092 million in the same period of the previous year.
  8. FY2024-Q2AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥731 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥731 million for the cumulative second quarter, up from ¥669 million in the cumulative second quarter of the previous year.
  9. FY2024-Q1AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥356 million during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥356 million for the first quarter, up from ¥317 million in the same period of the previous year. It was stated that there had been no material change in the status of the research and development activities.
  10. FY2023AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,431 million.」

    Research and development expenses amounted to ¥1,431 million, up from ¥1,366 million in the previous fiscal year.
  11. FY2023-Q3Research and development expenses declined slightly year on yearAnnual report

    「Research and development activities across the Group amounted to ¥1,092 million during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥1,092 million, down slightly from ¥1,101 million in the same period of the previous year. It was stated that there had been no material change in the status of the research and development activities.
  12. FY2023-Q2AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥724 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥724 million, up from ¥616 million in the cumulative second quarter of the previous year. It was stated that there had been no material change in the status of the research and development activities.
  13. FY2023-Q1AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥348 million during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥348 million for the first quarter, up from ¥318 million in the same period of the previous year. It was stated that there had been no material change in the status of the research and development activities.
  14. FY2022-Q3R&D expenses decreased year on yearAnnual report

    「Research and development activities across the Group amounted to ¥1,002 million during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥1,002 million, down from ¥1,101 million in the same period of the previous year. It was stated that there had been no material change in the status of the research and development activities themselves.
  15. FY2022-Q2AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥669 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥669 million, up from ¥616 million in the same quarter of the previous year. It was stated that there had been no material change in the status of research and development activities.
  16. FY2022-Q1Research and development activities declined slightlyAnnual report

    「Research and development activities across the Group amounted to ¥317 million during the cumulative first quarter of the current consolidated fiscal year. There was no material change in the status of the Group's research and development activities during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities declined slightly from ¥318 million in the same period of the previous year, but it was stated that there had been no material change in the status of the research and development activities.
  17. FY2021-Q3Research and development expenses continue to decline year on yearAnnual report

    「Research and development activities across the Group amounted to ¥929 million during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥929 million for the cumulative third quarter, down from ¥1,101 million in the same period of the previous year. It was stated that there had been no material change in the status of the research and development activities themselves.
  18. FY2021-Q2Research and development expenses decreased year on yearAnnual report

    「Research and development activities across the Group amounted to ¥616 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥616 million for the cumulative second quarter, down from ¥714 million in the same period of the previous year. It was stated that there had been no material change in the status of research and development activities.
  19. FY2021-Q1Research and development expenses decreased year on yearAnnual report

    「Research and development activities across the Group amounted to ¥318 million during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥318 million for the first quarter, down from ¥360 million in the same period of the previous year. It was stated that there had been no material change in the status of research and development activities.
  20. FY2020-Q3AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥1,101 million during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥1,101 million for the cumulative third quarter, up from ¥1,027 million in the same period of the previous year.
  21. FY2020-Q2AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥732 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥732 million for the cumulative second quarter, up from ¥666 million in the cumulative second quarter of the previous year.
  22. FY2020-Q1AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥360 million during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥360 million for the first quarter, up from ¥342 million in the same quarter of the previous year.
  23. FY2019AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,457 million.」

    Research and development expenses amounted to ¥1,457 million, up from approximately ¥1,400 million in the previous fiscal year.
  24. FY2019-Q3AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥1,102 million during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥1,102 million for the cumulative third quarter, up from ¥1,027 million in the cumulative third quarter of the previous year.
  25. FY2019-Q2AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥714 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥714 million for the cumulative second quarter, up from ¥633 million in the cumulative second quarter of the previous year.
  26. FY2019-Q1AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥342 million during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥342 million for the first quarter, up from ¥317 million in the same quarter of the previous year.
  27. FY2018AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,399 million.」

    Research and development expenses amounted to ¥1,399.979 million, up from ¥1,337.047 million in the previous fiscal year.
  28. FY2018-Q3AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥1,027 million during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥1,027 million for the cumulative third quarter, up from ¥952 million in the cumulative third quarter of the previous year.
  29. FY2018-Q2AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥666 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥666 million for the cumulative second quarter, up from ¥633 million in the cumulative second quarter of the previous year.
  30. FY2018-Q1AdvancedAnnual report

    「Research and development activities across the Group amounted to ¥317 million during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥317 million for the first quarter, up from ¥312 million in the same quarter of the previous year.
  31. FY2017AdvancedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,337 million.」

    Research and development expenses amounted to ¥1,337 million, up from ¥1,288.734 million in the previous fiscal year.
  32. FY2017-Q3RestatedAnnual report

    「Research and development activities across the Group amounted to ¥952 million during the cumulative third quarter of the current consolidated fiscal year. There was no material change in the status of the Group's research and development activities during the cumulative third quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥952 million for the cumulative third quarter, and it was stated that there had been no material change in the status of the activities.
  33. FY2017-Q2RestatedAnnual report

    「Research and development activities across the Group amounted to ¥633 million during the cumulative second quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥633 million for the cumulative second quarter, and it was stated that there had been no material change in the status of research and development activities.
  34. FY2017-Q1RestatedAnnual report

    「Research and development activities across the Group amounted to ¥312 million during the cumulative first quarter of the current consolidated fiscal year.」

    Research and development activities amounted to ¥312 million for the first quarter, as disclosed.
  35. FY2016First statedAnnual report

    「Total research and development expenses for the consolidated fiscal year were ¥1,288 million.」

    The total amount of research and development expenses for the consolidated fiscal year was disclosed.
Moved together

"Establishing new businesses and timely launches of new products" moved the same way as this thread, in the same document, in 17 of its 35 moves.

17171412119★123456
  1. ★This thread
  2. 1Establishing new businesses and timely launches of new products17×
  3. 2High-Performance Golf Shafts and Data-Driven Product Development17×
  4. 3Capital Investment, Productivity Improvement and Labor Savings, Centered on Growth Areas14×
  5. 4Performance-linked shareholder returns based on stable dividends12×
  6. 5Composition of Overseas Sales11×
  7. 6Operating profit growth and declines in ordinary profit and net income9×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Fujikura Composites yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.